Literature DB >> 30961490

Preterm Birth, Inflammation and Infection: New Alternative Strategies for their Prevention.

Víctor M Muñoz-Pérez1, Mario I Ortiz1, Raquel Cariño-Cortés1, Eduardo Fernández-Martínez1, Leticia Rocha-Zavaleta2, Mirandeli Bautista-Ávila3.   

Abstract

BACKGROUND: Worldwide, the progress in reducing neonatal mortality has been very slow. The rate of preterm birth has increased over the last 20 years in low-income and middle-income countries. Its association with increased mortality and morbidity is based on experimental studies and neonatal outcomes from countries with socioeconomic differences, which have considered implementing alternative healthcare strategies to prevent and reduce preterm births.
METHODS: Currently, there is no widely effective strategy to prevent preterm birth. Pharmacological therapies are directed at inhibiting myometrial contractions to prolong parturition. Some drugs, medicinal plants and microorganisms possess myorelaxant, anti-inflammatory and immunomodulatory properties that have proved useful in preventing preterm birth associated with inflammation and infection.
RESULTS: This review focuses on the existing literature regarding the use of different drugs, medicinal plants, and microorganisms that show promising benefits for the prevention of preterm birth associated with inflammation and infection. New alternative strategies involving the use of PDE-4 inhibitors, medicinal plants and probiotics could have a great impact on improving prenatal and neonatal outcomes and give babies the best start in life, ensuring lifelong health benefits.
CONCLUSION: Despite promising results from well-documented cases, only a small number of these alternative strategies have been studied in clinical trials. The development of new drugs and the use of medicinal plants and probiotics for the treatment and/or prevention of preterm birth is an area of growing interest due to their potential therapeutic benefits in the field of gynecology and obstetrics. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  PDE-4 inhibitors; Preterm birth; immunomodulation; infection; inflammation; medicinal plants; microbiota; probiotics.

Mesh:

Substances:

Year:  2019        PMID: 30961490     DOI: 10.2174/1389201020666190408112013

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  4 in total

1.  N,N-Dimethylformamide Delays LPS-Induced Preterm Birth in a Murine Model by Suppressing the Inflammatory Response.

Authors:  Zeng-Hui Wei; Oluwabukola O Salami; Jagadish Koya; Swapna Munnangi; Ryan Pekson; Charles R Ashby; Sandra E Reznik
Journal:  Reprod Sci       Date:  2022-03-29       Impact factor: 2.924

2.  Metabonomics profile analysis in inflammation-induced preterm birth and the potential role of metabolites in regulating premature cervical ripening.

Authors:  Yan Yan; Zhuorong Gu; Baihe Li; Xirong Guo; Zhongxiao Zhang; Runjie Zhang; Zheng Bian; Jin Qiu
Journal:  Reprod Biol Endocrinol       Date:  2022-09-06       Impact factor: 4.982

3.  Unprecedented reduction in births of very low birthweight (VLBW) and extremely low birthweight (ELBW) infants during the COVID-19 lockdown in Ireland: a 'natural experiment' allowing analysis of data from the prior two decades.

Authors:  Roy K Philip; Helen Purtill; Elizabeth Reidy; Mandy Daly; Mendinaro Imcha; Deirdre McGrath; Nuala H O'Connell; Colum P Dunne
Journal:  BMJ Glob Health       Date:  2020-09

4.  Hydrogen Sulfide Contributes to Uterine Quiescence Through Inhibition of NLRP3 Inflammasome Activation by Suppressing the TLR4/NF-κB Signalling Pathway.

Authors:  Zixi Chen; Mengzhe Zhang; Yunzhi Zhao; Wenjuan Xu; Fenfen Xiang; Xiaoxiao Li; Tao Zhang; Rong Wu; Xiangdong Kang
Journal:  J Inflamm Res       Date:  2021-06-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.